Otsuka Pharmaceutical Co., Ltd.

This phase 3 trial is testing the long-term safety of a daily pill called SEP-363856 for adults with schizophrenia. Researchers will monitor 100 Japanese participants for side effects over 52 weeks. The goal is to see if this drug can be a safe option for ongoing disease control.

This study tests the safety of an experimental drug called EB-1020, taken once daily, in 180 children and adolescents with ADHD over 52 weeks. Researchers will monitor side effects and how well participants tolerate the medication. The trial is open to those who completed a prior…

This study tests a new medication called EB-1020 for children and teenagers with ADHD. It is a once-daily capsule that aims to reduce symptoms like inattention and hyperactivity. The trial involves 315 participants in Japan and China, comparing two doses of the drug against a pla…

This study monitors the safety and effectiveness of the drug LUPKYNIS (voclosporin) in 400 adults with lupus nephritis under real-world conditions. Participants take LUPKYNIS alongside standard medications like steroids. The goal is to track side effects and see how well the drug…

This study tracks about 1,000 people with migraine who are taking AJOVY (fremanezumab) as part of their regular care. The goal is to see how safe the drug is over the long term, especially regarding heart problems. Researchers will also collect information on how well it works. T…